Skip to main content Accessibility help
×
Hostname: page-component-848d4c4894-2pzkn Total loading time: 0 Render date: 2024-06-13T07:45:27.000Z Has data issue: false hasContentIssue false

11 - Extended/supplementary prescribing: a public health perspective

Published online by Cambridge University Press:  10 January 2011

Molly Courtenay
Affiliation:
University of Surrey
Matt Griffiths
Affiliation:
University of the West of England, Bristol
Get access

Summary

In this chapter we consider the wider, public health context of independent/supplementary prescribing.

Public health

Public health is defined as ‘the science and art of preventing disease, prolonging life, and promoting health through the organised efforts of society’ (Acheson 1988). Public health professionals must consider health and disease in the widest possible context and take action to promote healthy lifestyles, prevent disease, protect and improve general health, and improve healthcare services (FPH 2009). Thus public health practice is focused on enhancing the health of the population as a whole, rather than necessarily treating individual patients. The definition of ‘population’ varies with context. This may be geographical (e.g. a locality like a general practice population), or in terms of particular client groups (e.g. children or people on low incomes) or people with specific health needs (e.g. people with diabetes or heart disease).

Public health personnel, working with other professional groups, fulfil a number of functions and, broadly speaking, their work usually falls within one or all of the following three domains: improving health; protecting health; and improving health services (FPH 2009). The work includes monitoring the health status of the population, identifying health needs, building programmes to reduce risk and screen for early disease, controlling and preventing communicable diseases, developing policies to promote health, planning and evaluating healthcare provision, and managing and implementing change (Chief Medical Officer 2003a).

Although delivering good health for the population is generally considered to involve more than simply prescribing medicines, two recent therapeutics-based public health interventions have been launched.

Type
Chapter
Information
Independent and Supplementary Prescribing
An Essential Guide
, pp. 130 - 146
Publisher: Cambridge University Press
Print publication year: 2010

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Acheson, E.D. (1988). Public Health in England: Report of the Committee of Inquiry into the Future Development of the Public Health Function. London: Department of Health.Google Scholar
Advisory Committee on the Microbiological Safety of Food (1992).
Alteri, C., Svicher, V., Gori, C. et al. Study Group S (2009). Characterisation of the patterns of drug resistance mutations in newly diagnosed HIV-1 infected patients naive to the antiretroviral drugs. BMC Infect Dis 9(1): 111.CrossRefGoogle Scholar
Anon. (1969). Report of the Joint Committee on the Use of Antimicrobials in Animal Husbandry and Veterinary Medicine (Swann Committee). London: HMSO.Google Scholar
Arnold, S.R., Straus, S.E. (2005). Interventions to improve antibiotic prescribing practices in ambulatory care. Cochrane Database Syst Rev (4): CD003539.Google Scholar
Cals, J.W., Boumans, D., Lardinois, R.J. et al. (2007). Public beliefs on antibiotics and respiratory tract infections: an internet-based questionnaire study. Br J Gen Pract 57(545): 942–947.CrossRefGoogle Scholar
Cattoir, V., Nordmann, P. (2009). Plasmid-mediated quinolone resistance in gram-negative bacterial species: an update. Curr Med Chem 16(8): 1028–1046.CrossRefGoogle ScholarPubMed
,Chief Medical Officer (2003a). Public Health in England. http://www.dh.gov.uk/en/Aboutus/MinistersandDepartmentLeaders/ChiefMedicalOfficer/Archive/FeaturesArchive/Browsable/DH_4102835 (accessed 22 July 2009).
,Chief Medical Officer (2003b). Winning Ways – Working Together to Reduce Healthcare Associated Infection in England. A Report from the Chief Medical Officer. London: Department of Health.Google Scholar
Cosgrove, S.E. (2006). The relationship between antimicrobial resistance and patient outcomes: mortality, length of hospital stay, and health care costs. Clin Infect Dis 42 (Suppl. 2): S82–S89.CrossRefGoogle ScholarPubMed
Cosgrove, S.E., Carmeli, Y. (2003). The impact of antimicrobial resistance on health and economic outcomes. Clin Infect Dis 36: 1433–1437.Google ScholarPubMed
Davey, P.G., Marwick, C. (2008). Appropriate vs. inappropriate antimicrobial therapy. Clin Microbiol Infect 14 (Suppl. 3): 15–21.CrossRefGoogle ScholarPubMed
Davey, P., Pagliari, C., Hayes, A. (2002). The patient's role in the spread and control of bacterial resistance to antibiotics. Clin Microbiol Infect 8 (Suppl 2): 43–68.CrossRefGoogle ScholarPubMed
Davey, P., Brown, E., Fenelon, L. et al. (2005). Interventions to improve antibiotic prescribing practices for hospital inpatients. Cochrane Database Syst Rev (4): CD003543.CrossRefGoogle ScholarPubMed
Delaney, J.A., Schneider-Lindner, V., Brassard, P. et al. (2008). Mortality after infection with methicillin-resistant Staphylococcus aureus (MRSA) diagnosed in the community. BMC Med 6: 2.CrossRefGoogle Scholar
Del Mar, C.B., Glasziou, P.P., Spinks, A.B. (2006). Antibiotics for sore throat. Cochrane Database Syst Rev (4): CD000023.Google ScholarPubMed
,Department of Health (2000). UK Antimicrobial Resistance Strategy and Action Plan. London: Department of Health. http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_4007783 (accessed 22 July 2009).Google Scholar
,Department of Health (2002). Antibiotics – Don't Wear Me Out. http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_4007460 (accessed 28 July 2009).
,Department of Health (2003a). Hospital Pharmacy Initiative for Promoting Prudent Use of Antibiotics in Hospitals. London: Department of Health. (Professional Letter. Chief Medical Officer: PLCMO (2003)3.) http://www.dh.gov.uk/en/Publicationsandstatistics/Lettersandcirculars/Professionalletters/Chiefmedicalofficerletters/DH_4004614 (accessed 29 July 2009).Google Scholar
,Department of Health (2003b). Building on the Best – Choice, Responsiveness and Equity in the NHS. A Summary. London: Department of Health.Google Scholar
,Department of Health (2004a). Towards Cleaner Hospitals and Lower Rates of Infection: a Summary of Action. London: Department of Health. http://www.dh.gov.uk/en/Publichealth/Healthprotection/Healthcareacquiredinfection/Healthcareacquiredgeneralinformation/index.htm (accessed 28 July 2009).Google Scholar
,Department of Health (2004b). Standards for Better Health – Health Care Standards for Services Under the NHS. A Consultation. London: Department of Health.Google Scholar
,Department of Health (2008a). Pharmacy in England: Building on Strengths – Delivering the Future. London: TSO (Cm 7341).Google Scholar
,Department of Health (2008b). The ‘Green Book’ chapter on human papillomavirus (HPV). http://www.dh.gov.uk/en/Publichealth/Healthprotection/Immunisation/Green book/DH_4097254. (accessed 29 July 2009).
,Department of Health, National Assembly for Wales, Scottish Executive Health Department, DHSS PS (Northern Ireland), Public Health Laboratory Service Communicable Disease Surveillance Centre (2001). Health Information for Overseas Travel. London: The Stationery Office (also known as the ‘Yellow Book’).Google Scholar
,Department of Health, Welsh Office, Scottish Office Department of Health, DHSS (Northern Ireland). (2006). Immunisation Against Infectious Disease (eds Salisbury, D., Ramsay, M., Noakes, K.). London: HMSO (also known as the ‘Green Book’).Google Scholar
,Department of Health (2009). Antibiotic campaign 2008–2009. Available at http://www.dh.gov.uk/en/Publichealth/Patientsafety/Antibioticresistance/DH_082512 (accessed 8th February 2010).
,Faculty of Public Health (2009). Public Health – Specialise in the ‘Bigger Picture’. http://www. fph.org.uk/careers/assets/files/ph_careers_booklet.pdf (accessed 8th February 2010).
Fenner, F. (1993). Smallpox: emergence, global spread, and eradication. Hist Philos Life Sci 15(3): 397–420.Google Scholar
Fisher, K., Phillips, C. (2009). The ecology, epidemiology and virulence of Enterococcus. Microbiology 155(Pt 6): 1749–1757.CrossRefGoogle ScholarPubMed
Goldstein, M.R., Mascitelli, L., Pezzetta, F. (2009). Primary prevention of cardiovascular disease with statins: cautionary notes. QJM 102(11): 817–820.CrossRefGoogle ScholarPubMed
Gross, P.A., Pujat, D. (2001). Implementing practice guidelines for appropriate antimicrobial usage: a systematic review. Med Care 39 (Suppl. 2): II55–II69.CrossRefGoogle ScholarPubMed
Hawker, J., Begg, N., Blair, I. et al. (2005). Communicable Disease Control Handbook (second edition). Oxford: Blackwell Sciences.CrossRefGoogle Scholar
,Health Protection Agency (2008). Antimicrobial Resistance and Prescribing in England, Wales and Northern Ireland, 2008. http://www.hpa.org.uk/web/HPAwebFile/HPAweb_C/1216798080469 (accessed 22 July 2009).
Helms, M., Vastrup, P., Gerner-Smidt, P. et al. (2002). Excess mortality associated with antimicrobial drug-resistant Salmonella typhimurium. Emerg Infect Dis 8: 490–495.CrossRefGoogle ScholarPubMed
Holmes, J.H., Metlay, J., Holmes, W.C. et al. (2003). Developing a patient intervention to reduce antibiotic overuse. Proc AMIA Symp 2003: 864.Google Scholar
,House of Lords Select Committee on Science and Technology (1998). Resistance to Antibiotics and Other Antimicrobial Agents. 7th Report 1997–98, HL Paper 81. London: Stationery Office.Google Scholar
Idelevich, E., Kirch, W., Schindler, C. (2009). Current pharmacotherapeutic concepts for the treatment of obesity in adults. Ther Adv Cardiovasc Dis 3(1): 75–90.CrossRefGoogle ScholarPubMed
,Interdepartmental Steering Group on Resistance to Antibiotics and Other Antimicrobial Agents (2001). Clinical Prescribing Subgroup. Optimising the Clinical Use of Antimicrobials: Report and Recommendations for Further Work. London: Department of Health. http://www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/@dh/@en/documents/digitalasset/dh_4084395.pdf (accessed 29 July 2009).
Johnsen, P.J., Townsend, J.P., Bøhn, T. et al. (2009). Factors affecting the reversal of antimicrobial-drug resistance. Lancet Infect Dis 9(6): 357–364.CrossRefGoogle ScholarPubMed
Johnson, A.P., Pearson, A., Duckworth, G. (2005). Surveillance and epidemiology of MRSA bacteraemia in the UK. J Antimicrob Chemother 56(3): 455–462.CrossRefGoogle ScholarPubMed
Jonges, M., Lubben, I.M., Dijkstra, F. et al. (2009). Dynamics of antiviral-resistant influenza viruses in the Netherlands, 2005–2008. Antiviral Res 83(3): 290–297.CrossRefGoogle ScholarPubMed
Kan, B., Berggren, I., Ghebremichael, S. et al. (2008). Extensive transmission of an isoniazid-resistant strain of Mycobacterium tuberculosis in Sweden. Int J Tuberc Lung Dis 12(2): 199–204.Google ScholarPubMed
Keuleyan, E., Gould, M. (2001). Key issues in developing antibiotic policies: from an institutional level to Europe-wide. European Study Group on Antibiotic Policy (ESGAP), Subgroup III. Clin Microbiol Infect 7 (Suppl 6): 16–21.CrossRefGoogle Scholar
Kilgore, M., Brossette, S. (2008). Cost of bloodstream infections. Am J Infect Control 36(10): S172.e1–3.CrossRefGoogle ScholarPubMed
Kilgore, M.L., Ghosh, K., Beavers, C.M. et al. (2008). The costs of nosocomial infections. Med Care 46(1): 101–104.CrossRefGoogle ScholarPubMed
Kumar, S., Little, P., Britten, N. (2003). Why do General Practitioners prescribe antibiotics for sore throat? Grounded theory interview study. BMJ 326: 138.CrossRefGoogle ScholarPubMed
Lancet (2009). Over-the-counter medicines: in whose best interests?Lancet 373(9661): 354.CrossRefGoogle Scholar
Leclercq, R. (2009). Epidemiological and resistance issues in multidrug-resistant staphylococci and enterococci. Clin Microbiol Infect 15(3): 224–231.CrossRefGoogle ScholarPubMed
Lee, S.Y., Kotapati, S., Kuti, J.L. et al. (2006). Impact of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species on clinical outcomes and hospital costs: a matched cohort study. Infect Control Hosp Epidemiol 27(11): 1226–1232.CrossRefGoogle ScholarPubMed
Livermore, D.M., Canton, R., Gniadkowski, M. et al. (2007). CTX-M: changing the face of ESBLs in Europe. J Antimicrob Chemother 59: 165–174.CrossRefGoogle Scholar
Lyytikäinen, O., Kanerva, M., Agthe, N. et al. (2005). Finnish Prevalence Survey Study Group. 2008. Healthcare-associated infections in Finnish acute care hospitals: a national prevalence survey. J Hosp Infect 69(3): 288–294.CrossRefGoogle Scholar
Macfarlane, J., Holmes, W., Macfarlane, R. et al. (1997a). Influence of patients' expectations on antibiotic management of acute lower respiratory tract illness in general practice: questionnaire study. BMJ 315: 1211–1214.CrossRefGoogle ScholarPubMed
Macfarlane, J.T., Holmes, W.F., Macfarlane, R.M. (1997b). Reducing reconsultations for acute lower respiratory tract illness with an information leaflet: a randomised controlled study of patients in primary care. Br J Gen Pract 47: 719–722.Google Scholar
Mangione-Smith, R., Elliott, M.N., Stivers, T. et al. (2004). Racial/ethnic variation in parent expectations for antibiotics: implications for public health campaigns. Pediatrics 113(5): e385–e94.CrossRefGoogle ScholarPubMed
Mangione-Smith, R., Elliott, M.N., Stivers, T. et al. (2006). Ruling out the need for antibiotics: are we sending the right message?Arch Pediatr Adolesc Med 160(9): 945–952.CrossRefGoogle ScholarPubMed
Maragakis, L.L., Perencevich, E.N., Cosgrove, S.E. (2008). Clinical and economic burden of antimicrobial resistance. Expert Rev Anti Infect Ther 6(5): 751–763.CrossRefGoogle ScholarPubMed
McGowan, J.E.. (2001). Economic impact of antimicrobial resistance. Emerg Infect Dis 7: 286–292.CrossRefGoogle ScholarPubMed
McTigue, A. (2004). Taking stock: risk and remedy. MPS Casebook 12(1): 8–10. http://www.medicalprotection.org/uk/casebook/february2004 (accessed 28 July 2009).Google Scholar
McTigue, A., Williams, S. (2003). Have confidence in confidence alone. MPS Casebook 11(4): 8–10. http://www.medicalprotection.org/uk/casebook/november2003 (accessed 29 July 2009).Google Scholar
Mölstad, S., Erntell, M., Hanberger, H. et al. (2008). Sustained reduction of antibiotic use and low bacterial resistance: 10-year follow-up of the Swedish Strama programme. Lancet Infect Dis 8(2): 125–132.CrossRefGoogle ScholarPubMed
,NHS Prescription Services (2009). Update on Growth in Prescription Volume and Cost in the Year to March 2009. http://www.nhsbsa.nhs.uk/PrescriptionServices/Documents/Volume_and_cost_year_to_March_2009.pdf (accessed 23 July 2009).
,NICE (2003). NICE Clinical Guideline 2. Infection Control: Prevention of Healthcare-Associated Infection in Primary and Community Care. http://www.nice.org.uk/nicemedia/pdf/Infection_control_fullguideline.pdf (accessed 29 July 2009).
,NICE (2007). NICE Clinical Guideline 54. Urinary Tract Infection in Children: Diagnosis, Treatment and Long-Term Management. http://www.nice.org.uk/nicemedia/pdf/CG54NICEguideline.pdf (accessed 28 July 2009).
,NICE (2008). NICE Clinical Guideline 69. Respiratory Tract Infections – Antibiotic Prescribing. Prescribing of Antibiotics for Self-Limiting Respiratory Tract Infections in Adults and Children in Primary Care. http://www.nice.org.uk/nicemedia/pdf/CG69FullGuideline.pdf (accessed 28 July 2009).
Nicolau, D.P. (2009). Containing costs and containing bugs: are they mutually exclusive?J Manag Care Pharm 15(2 Suppl): S12–S17.Google ScholarPubMed
O'Brien, F.G., Lim, T.T., Chong, F.N. et al. (2004). Diversity among community isolates of methicillin-resistant Staphylococcus aureus in Australia. J Clin Microbiol 42: 3185–3190.CrossRefGoogle ScholarPubMed
Parry, C.M., Threlfall, E.J. (2008). Antimicrobial resistance in typhoidal and nontyphoidal salmonellae. Curr Opin Infect Dis 21(5): 531–538.CrossRefGoogle ScholarPubMed
Pellowe, C.M., Pratt, R.J., Harper, P. et al. (2003). Evidence-based guidelines for preventing healthcare-associated infections in primary and community care in England. J Hosp Infect 55 Suppl. 2: S2–S127.CrossRefGoogle ScholarPubMed
Pflomm, J.M. (2002). Strategies for minimizing antimicrobial resistance. Am J Health Syst Pharm 59 Suppl 3: S12–S15.
Plowman, R., Graves, N., Griffin, M.A. et al. (2001). The rate and cost of hospital-acquired infections occurring in patients admitted to selected specialties of a district general hospital in England and the national burden imposed. J Hosp Infect 47: 198–209.CrossRefGoogle ScholarPubMed
Pratt, R.J., Pellowe, C.M., Wilson, J.A. et al. (2007). epic2: National evidence-based guidelines for preventing healthcare-associated infections in NHS hospitals in England. J Hosp Infect 65S: S1–S64.CrossRefGoogle Scholar
Reeves, D. (2007). The 2005 Garrod Lecture: The changing access of patients to antibiotics – for better or worse?J Antimicrob Chemother 59: 333–341.CrossRefGoogle ScholarPubMed
Reilly, J., Stewart, S., Allardice, G.A. et al.(2008). Results from the Scottish National HAI Prevalence Survey. J Hosp Infect 69(1): 62–68.CrossRefGoogle ScholarPubMed
Saizy-Callaert, S., Causse, R., Furhman, C. et al. (2003). Impact of a multidisciplinary approach to the control of antibiotic prescription in a general hospital. J Hosp Infect 53(3): 177–182.CrossRefGoogle ScholarPubMed
Schmid, D., Fretz, R., Kuo, H.W. et al. (2008). An outbreak of multidrug-resistant tuberculosis among refugees in Austria, 2005–2006. Int J Tuberc Lung Dis 12(10): 1190–1195.Google Scholar
,Scottish Government (2002). Antimicrobial Resistance Strategy and Scottish Action Plan. http://www.scotland.gov.uk/Publications/2002/06/14962/7808 (accessed 29 July 2009).
Seppälä, H., Klaukka, T., Vuopio-Varkila, J. et al. (1997). The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. N Engl J Med 337: 441–446.CrossRefGoogle Scholar
Small, C.B., Bachert, C., Lund, V.J. et al. (2007). Judicious antibiotic use and intranasal corticosteroids in acute rhinosinusitis. Am J Med 120(4): 289–294.CrossRefGoogle ScholarPubMed
,Standing Medical Advisory Committee (1998) Sub-group on Antimicrobial Resistance. The Path of Least Resistance. London: Department of Health.Google Scholar
Stone, P.W., Braccia, D., Larson, E. (2005). Systematic review of economic analyses of health care-associated infections. Am J Infect Control 33(9): 501–509.CrossRefGoogle ScholarPubMed
Sunenshine, R.H., Wright, M.O., Maragakis, L.L. et al. (2007). Multidrug-resistant Acinetobacter infection mortality rate and length of hospitalization. Emerg Infect Dis 13(1): 97–103.CrossRefGoogle ScholarPubMed
Tapsall, J.W. (2003). Monitoring antimicrobial resistance for public health action. Commun Dis Intell 27 Suppl: S70–S74.Google ScholarPubMed
Thanaviratananich, S., Laopaiboon, M., Vatanasapt, P. (2008). Once or twice daily versus three times daily amoxicillin with or without clavulanate for the treatment of acute otitis media. Cochrane Database Syst Rev (4): CD004975.Google Scholar
Tollefson, L., Karp, B.E. (2004). Human health impact from antimicrobial use in food animals. Med Mal Infect 34(11): 514–521.CrossRefGoogle ScholarPubMed
,UK Parliament (2002) Lords Hansard text for 24 January 2002 (220124–21). http://www.publications.parliament.uk/pa/ld200102/ldhansrd/vo020124/text/20124–21.htm (accessed 29 July 2009).
Vouloumanou, E.K., Karageorgopoulos, D.E., Kazantzi, M.S. et al. (2009). Antibiotics versus placebo or watchful waiting for acute otitis media: a meta-analysis of randomized controlled trials. J Antimicrob Chemother 64(1): 16–24.CrossRefGoogle ScholarPubMed
Ward, S., Lloyd Jones, M., Pandor, A. et al. (2007). A systematic review and economic evaluation of statins for the prevention of coronary events. Health Technol Assess 11(14): 1–160, iii-iv.CrossRefGoogle ScholarPubMed
Wassenaar, T.M. (2005). Use of antimicrobial agents in veterinary medicine and implications for human health. Crit Rev Microbiol 31(3): 155–69.CrossRefGoogle ScholarPubMed
Weinstock, D.M., Zuccotti, G. (2009). The evolution of influenza resistance and treatment. JAMA 301: 1066–1069.CrossRefGoogle ScholarPubMed
Woodfordm, N, Ellington, M.J. (2007). The emergence of antibiotic resistance by mutation. Clin Microbiol Infect 13: 5–18.CrossRefGoogle Scholar
Zetola, N., Francis, J.S., Nuermberger, E.L. et al. (2005). Community-acquired methicillin-resistant Staphylococcus aureus: an emerging threat. Lancet Infect Dis 5: 275–286.CrossRefGoogle Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×